IERARDI, ENZO GIANNI
 Distribuzione geografica
Continente #
NA - Nord America 4.700
EU - Europa 4.034
AS - Asia 1.547
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 8
AF - Africa 5
SA - Sud America 1
Totale 10.308
Nazione #
US - Stati Uniti d'America 4.693
IE - Irlanda 1.526
CN - Cina 1.162
UA - Ucraina 1.033
SE - Svezia 723
IT - Italia 223
TR - Turchia 212
FI - Finlandia 168
IN - India 156
FR - Francia 137
GB - Regno Unito 120
DE - Germania 53
BE - Belgio 17
RU - Federazione Russa 15
EU - Europa 13
VN - Vietnam 13
CZ - Repubblica Ceca 10
CA - Canada 7
AU - Australia 4
EG - Egitto 4
NL - Olanda 4
NZ - Nuova Zelanda 4
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
GE - Georgia 1
HK - Hong Kong 1
ID - Indonesia 1
KE - Kenya 1
PL - Polonia 1
SG - Singapore 1
SM - San Marino 1
Totale 10.308
Città #
Dublin 1.525
Chandler 917
Jacksonville 732
Dearborn 580
Nyköping 374
Nanjing 373
Wilmington 218
Princeton 146
Ashburn 144
San Mateo 144
Beijing 139
Nanchang 115
Boardman 114
Woodbridge 85
Kunming 73
Hebei 69
Shenyang 69
Ann Arbor 63
Tianjin 59
Des Moines 58
Changsha 50
Jiaxing 43
Philadelphia 40
Hilden 34
Hangzhou 30
Jinan 30
Stevenage 28
Seattle 27
New York 23
Helsinki 22
Pune 18
Brussels 17
Changchun 17
Ningbo 15
Dong Ket 12
Norwalk 12
Taizhou 12
Auburn Hills 11
Zhengzhou 11
Lanzhou 10
Rome 10
Brno 9
Guangzhou 8
Hefei 7
Shanghai 7
Hanover 6
Florence 5
Fuzhou 5
Napoli 5
Saint Petersburg 5
Borås 4
Fairfield 4
Los Angeles 4
Orange 4
Washington 4
Asti 3
Auckland 3
Bologna 3
Casoria 3
Cedar Knolls 3
Irvine 3
Messina 3
Milan 3
Mountain View 3
Sydney 3
Varedo 3
Amsterdam 2
Avigliano 2
Bari 2
Busto Arsizio 2
Foggia 2
Greenwich 2
Haikou 2
Houston 2
Jinhua 2
Kansas City 2
Las Vegas 2
Marta 2
Modena 2
Monreale 2
Montreal 2
Mumbai 2
Opera 2
Pescantina 2
Rockville 2
San Donà Di Piave 2
Toronto 2
Afragola 1
Albano Laziale 1
Andover 1
Arezzo 1
Arluno 1
Bagheria 1
Binh Duong 1
Brasília 1
Cairo 1
Chervonyy Donets 1
Chieti 1
Citta Sant'angelo 1
Clarks Summit 1
Totale 6.634
Nome #
LA COLITE SEGMENTARIA ASSOCIATA AI DIVERTICOLI: USO DEL DEL bECLOMETASONE dipropionatoNELLE FORME EMORRAGICHE 287
Helicobacter Heilmannii: un nuovo batterio dello stomaco. Come si ricerca e suo ruolo nella pratica clinica 129
Onset of liver damage after a single administration of infliximab in a patient with refractory ulcerative colitis. 107
"Clarithromycin-resistant genotypes and eradication of Helicobacter pylori." 102
Argon plasma coagulation in the treatment of haemorragic solitary ulcer syndrome. 100
57. M Barone, E Maiorano, R Ladisa, A Pece, P Berloco, M Strazzabosco, ML Caruso, AM Valentini, E Ierardi, A Di Leo, A Francavilla. Ursodeoxycholate further increases bile duct cell proliferative response induced by partial bile duct ligation in rats. 95
Liver damage onset after a single infliximab administration in a patient with refractory ulcerative colitis 94
Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab. 94
Pseudotumoural lesion of the abdominal wall due to a fishbone migration 92
The augmenter of liver regeneration induces mithochondrial gene expression in rat liver and enhances oxidative phosphorylation capacity of liver mithochondria. 91
Helicobacter pylori and chronic antral erosions: our experience. 90
Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV seronegative pregnant women: a 24 month prospective study. 87
Binding of Campylobacter pylori to human peripheral blood lymphocytes 87
H. pylori antibiotic resistance and 13C urea breath test values. J Med Microbiol. 2010 Jan 21. 87
Argon plasma coagulation of haemorragic solitary rectal ulcer syndrome. 87
Peritoneo-venous shunting for ascites: a five year experience with LeVeen and Denver shunts. 86
A case of adverse reaction potentially related to a microbubble contrast agent for ultrasonography. 86
Malnutrizione in Gastroenterologia. 85
Modulation of rat Hepatocyte proliferation by bile salts: in vitro and in vivo studies 85
Circadian rhythm of hepatic estrogen receptors. 84
Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost-effectiveness 84
Circadian rhythm of hepatic estrogen receptors 84
H. pylori vacA arrangement and related diseases: a retrospective study over a period of 15 years 83
I breath tests nell’ insufficienza panctreatica, nelle malattie epatiche e nell’ alitosi. 83
Acid exposure and altered acid clearance in GERD patients treated for Helicobacter pylori infection. 83
"Nutrizione in Gastroenterologia" 81
Epidemiology of gastroesophageal reflux 81
An inter and intra-laboratory comparison of breath 13CO2 . 80
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits 80
Incidence and risk factors of duodenal ulcer 79
A life threatning event following the injection of a microbubble contrast agent for ultrasonography. 79
Endoscopic ultrasound localization of a solitary insulinoma of pancreatic tail misdiagnosed as epilepsy: case report 79
Autoantibodies reacting with gastric antigens in Helicobacter pylori gastritis of dyspeptic children 78
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses. 78
Immunohistostaining of hepatitis C virus (HCV) non-structural protein 4 (NS 4) in ependymocytes of uninfected mice: an antigenic mimicry? 78
Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicenter study. 78
Pattern of apoptosis in Crohn’ s disease: a singular aspect. 76
"Alterazioni dello stato nutrizionale" 76
Cyclic nucleotides in ascites from ovarian carcinoma 76
The pattern of mucosal tumor necrosis factor-α expression in segmental colitis associated to diverticula suggests a truly autonomous clinical entity. 75
I nucleotidi ciclici (cAMP e cGMP) nell' ascite come markers di recidiva da carcinoma ovarico. 75
A third-line levofoxacin-based rescue therapy for Helicobacter pylori eradication. 74
Gastrospirillum hominis and human chronic gastritis 74
Update on Helicobacter pylori research. Malignancies. 74
Guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy. 74
Effect of Lactobacillus reuteri on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy in children: a randomised clinical trial 74
Immunohistochemical detection of Helicobacter Pylori vacuolating cytoxin in the hepatocytes of patients with isolated hypertransaminasemia 74
Helicobacter species in liver and biliary diseases. 73
Gastric epithelial cell proliferation and ras oncogene p21 expression in first-degree relatives of gastric cancer patients: a case-control study. 73
Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. 73
A serologic survey of Helicobacter pylori infection in 3281 Italian patients endoscoped for upper gastrintestinal symptoms 72
Influence of ursodeoxycholate-enriched diet on liver tumor growth in HBV transgenic mice 72
Symptoms and pathophysiological correlations in patients with constipation and functional dyspepsia. 72
ER-beta expression in large bowel adenomas: Implications in colon carcinogenesis. 72
Role of different clarithromycin resistance genotypes on Helicobacter pylori eradication. 72
A new semiquantitative method of quantifying Helicobacter pylori antigen in stools 72
Estrogens, androgens and EGF receptor expression in gastric carcinoma induced by N-methyl-N'-nitro-N-nitrosoguanidine. 71
Minimal inhibitory concentration (MIC) values and different point mutations in the 23S rRNA gene for clarithromycin resistance in Helicobacter pylori 71
There is a role for sequential in sequential anti-H. pylori therapy? (Reply of the authors). 71
Endoultrasonographic guided alcohol lavage of a pancreatic fluid collection: a case report 71
Treatment of a pancreatic endocrine tumor by ethanol injection guided by endoscopic ultrasound. 71
Campylobacter fetus bacteriemia in an immunocompromised patient: a case report and review of literature. 71
TUMOUR NECROSIS FACTOR ALPHA DOWNREGULATION AND BASIC FIBROBLAST GROWTH FACTOR/SYNDECAN 1 LINK: A POSSIBLE MOLECULAR PATHWAY OF MUCOSAL HEALING IN ULCERATIVE COLITIS 70
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 70
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. 70
Two new treatment regimens for Helicobacter pilori eradication: a randomised study 70
Gastro-esophageal reflux disease and lactose malabsorption: casual comorbidity or neglected association? 70
Effect of Helicobacter pylori eradication on intestinal metaplasia and gastric epithelium proliferation 70
Pathways and gene expression profiles in hepatocellular carcinoma 70
Malattia da reflusso gastro-esofageo e dispepsia non ulcerosa. 69
Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis. 69
Effect of eradicating therapy on cell proliferation in Helicobacter pylori-related lesions 69
Altered molecular pattern of mucosal healing in Crohn's disease fibrotic stenosis. 69
Helicobacter Heilmannii gastritis: a histological and immunohistochemical trait 68
Demonstration of a direct stimulatory effect of bile salts on rat colonic epithelial cell proliferation. 68
Segmental colitis associated with diverticula: A rare clinical entity and a new challenge for the gastroenterologist. 68
Tumour necrosis factor alpha and apoptosis in Helicobacter pylori related progressive gastric damage: a possible mechanism of immune system involvement in epithelial turnover regulation 68
Claritromycin resistance and Helicobacter pylori genotypes in Italy. 68
Proliferative Activity of Gastric Epithelium in Progressive Stages of Helicobacter pylori Infection. 68
Ruolo attuale e progressi tecnologici dell’ecografia transaddominale nell’ imaging delle vie biliari 68
High eradication rates for Helicobacter pylori with a new sequential treatment. 67
Anisakis pegreffi etiological agent of gastric infections in two Italian women. 67
The Influence of Lactobacillus brevis on Ornithine Decarboxylase Activity and Polyamine Profiles in Helicobacter pylori Infected Gastric Mucosa 67
Tumor necrosis alpha serum levels parallels isolated hypertransaminasemia in the third trimester of pregnancy 67
Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? 67
Effects of carbonated water on functional dyspepsia and constipation. 66
Celiac plexus under endoscopy ultrasonographic guidance complication. 66
Reflux symptoms in professional opera choristers. 66
“Mycophenolate mofetil in the treatment of autoimmune hcv-associated haematological disorders showing steroid resistance or dependence.” J Viral Hepat 66
Tumor necrosis factor alpha in segmental colitis associated with diverticula. 66
Worldwide H. pylori antibiotic resistance: a systematic review. 66
Molecular mechanisms of augmenter of liver regeneration as immunoregulator: its effect on inteferon-g expression in rat liver. 65
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. 65
The prolongation of triple therapy for Helicobacter pylori does not allows reaching therapeutic outcome of sequential scheme: a prospective, randomized study. 65
Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. 65
A oral Tacrolimus long-term therapy in parients with Crohn’s disease and steroid resistance 65
Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: a multicentre study. 65
Lupus nephritis improvement after anti-tumour necrosis factor alpha monoclonal antibody (Infliximab) treatment for Crohn’s disease: a case report. 65
Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis 64
Gastric Mucosa Alterations in First-Degree Relatives of Gastric Cancer Patients 64
Totale 7.798
Categoria #
all - tutte 36.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.321


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019275 0 0 0 0 0 0 0 5 25 32 79 134
2019/20202.342 532 296 57 56 287 327 319 21 188 28 187 44
2020/20211.135 161 1 154 9 152 154 165 10 153 157 5 14
2021/2022729 147 0 1 10 62 30 35 66 94 69 41 174
2022/20233.703 250 125 114 272 279 387 41 240 1.778 24 84 109
2023/2024429 113 28 23 18 69 149 1 28 0 0 0 0
Totale 10.358